Abstract
In order to achieve a high efficacy in cancer therapies which use radiation and/or hyperthermia, it is necessary to study and understand two important signal transduction pathways which can depress cell survival signals and simultaneously enhance cell death signals. Recent progress in molecular biology has provided information about these molecules and the associated mechanisms involved in their signaling and functioning. Targeting therapies have thus been examined to look for those which can affect genes capable of inducing a high efficiency in killing cancer cells after exposures to radiation and/or hyperthermia therapies. Target genes which function in cell survival signal transduction pathways, DNA repair, and protein repair are of primary interest. In contrast, apoptosis- and necrosis-inducing factors have an important role in leading to cell death in response to therapies. In this review, results from recent research efforts in Nara University are discussed.
Keywords: p53, signal transduction, radiation, hyperthermia, cancer therapy
Current Signal Transduction Therapy
Title: Signal Transduction of Radiation and/or Hyperthermic Cancer Therapies
Volume: 5 Issue: 3
Author(s): Takeo Ohnishi and Akihisa Takahashi
Affiliation:
Keywords: p53, signal transduction, radiation, hyperthermia, cancer therapy
Abstract: In order to achieve a high efficacy in cancer therapies which use radiation and/or hyperthermia, it is necessary to study and understand two important signal transduction pathways which can depress cell survival signals and simultaneously enhance cell death signals. Recent progress in molecular biology has provided information about these molecules and the associated mechanisms involved in their signaling and functioning. Targeting therapies have thus been examined to look for those which can affect genes capable of inducing a high efficiency in killing cancer cells after exposures to radiation and/or hyperthermia therapies. Target genes which function in cell survival signal transduction pathways, DNA repair, and protein repair are of primary interest. In contrast, apoptosis- and necrosis-inducing factors have an important role in leading to cell death in response to therapies. In this review, results from recent research efforts in Nara University are discussed.
Export Options
About this article
Cite this article as:
Ohnishi Takeo and Takahashi Akihisa, Signal Transduction of Radiation and/or Hyperthermic Cancer Therapies, Current Signal Transduction Therapy 2010; 5 (3) . https://dx.doi.org/10.2174/157436210791920283
DOI https://dx.doi.org/10.2174/157436210791920283 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Microtubule Targeting Agents: A Benchmark in Cancer Therapy
Current Drug Therapy Novel Therapies Against Aggressive and Recurrent Epithelial Cancers by Molecular Targeting Tumor- and Metastasis-Initiating Cells and Their Progenies
Anti-Cancer Agents in Medicinal Chemistry Nodule Size Effect on Diagnostic Performance of Ultrasonography and Computed Tomography for Papillary Thyroid Carcinoma
Current Medical Imaging Chronic Inflammatory Diseases: Progress and Prospect with Herbal Medicine
Current Pharmaceutical Design Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis
Current Genomics The Role of XRCC4 in Carcinogenesis and Anticancer Drug Discovery
Recent Patents on Anti-Cancer Drug Discovery Sp/KLF Family and Tumor Angiogenesis in Pancreatic Cancer
Current Pharmaceutical Design In vivo 19F MR Studies of Fluorine Labeled Photosensitizers in a Murine Tumor Model
Current Drug Discovery Technologies PET Tracers Based on 86Y
Current Radiopharmaceuticals Expression of P-gp, MRP, LRP, GST-π and TopoIIα and Acquired Resistance to Cisplatin in Human Lung Adenocarcinoma Cells
Letters in Drug Design & Discovery Drug Targeting Approaches and Use of Drug Delivery Systems in Management of Cancer
Current Pharmaceutical Design New Developments in Systemic Therapy for Hepatocellular Carcinoma
Current Cancer Therapy Reviews Signal Transduction Therapy for Cancer - Whither Now?
Current Signal Transduction Therapy IDO+ DCs and Signalling Pathways
Current Cancer Drug Targets Nanoparticle-based Drug Delivery Systems for Solid Brain Tumors
Current Nanoscience Radiolabeling Methods and Nuclear Imaging Techniques in the Design of New Polymeric Carriers for Cancer Therapy
Current Applied Polymer Science Selenium Derivatives as Cancer Preventive Agents
Current Medicinal Chemistry - Anti-Cancer Agents Novel Epigenetic Targets in Lymphoproliferative Disorders
Current Cancer Drug Targets Cancer Stem Cells – Are Surface Markers Alone Sufficient?
Current Stem Cell Research & Therapy Journey Describing the Cytotoxic Potential of Withanolides: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery